This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Suppression of Thyroid Radioiodine Uptake by Various Doses of Stable Iodide

List of authors.
  • Elliot Sternthal, M.D.,
  • Leslie Lipworth, M.B.,
  • Bruce Stanley, B.S.,
  • Cynthia Abreau, B.S.,
  • Shih-Lieh Fang, Ph.D.,
  • and Lewis E. Braverman, M.D.

Abstract

We studied the effect of various doses of sodium iodide on thyroid radioiodine uptake in euthyroid volunteers by giving single doses of 10, 30, 50, and 100 mg and then daily doses of 10, 15, 30, 50, or 100 mg for 12 days thereafter. All single doses above 10 mg suppressed 24-hour thyroid uptake of 123I to 0.7 to 1.5 per cent. Continued daily administration of 15 mg of iodide or more resulted in values consistently below 2 per cent.

A small but statistically significant fall in serum thyroxine (T4) and triiodothyronine (T3) and a rise in serum thyrotropin (TSH) concentrations were observed after eight and 12 days of iodide treatment. These data suggest that the thyroid uptake of radio-active iodine can be markedly suppressed by single-dose administration of 30 mg of stable iodide and that suppression can be maintained with daily doses of at least 15 mg. This study provides guidelines for stable iodide prophylaxis in the event of exposure to radio-active iodine. (N Engl J Med. 1980; 303:1083–8.)

Funding and Disclosures

Supported by research grants (AM 18919 and AM 07302) from the National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Md.

Presented in part at the annual meeting of the American Thyroid Association, November 5 6 7–8, 1980, San Diego, Calif.

We are indebted to Ms. Cindy A. Rice, M.S.P.H., for statistical assistance.

Author Affiliations

From the Division of Endocrinology and Metabolism and the departments of Medicine, Nuclear Medicine, and Family and Community Medicine, University of Massachusetts Medical School, Worcester, Mass, (address reprint requests to Dr. Braverman at the Division of Endocrinology and Metabolism, University of Massachusetts Medical School, 55 Lake Ave. N., Worcester, MA 01605).

Print Subscriber? Activate your online access.